跳至主要内容
临床试验/KCT0001031
KCT0001031招募中未知

8 weeks, single-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Citrus junos Siebold ex Tanaka extract on inhibition of platelet aggregation and blood circulation

Ajou University0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
Male

入选标准

  • 1) Male adult smokers more than 10 cigarettes per day
  • 2) Platelet eggregation results > 70% at screening
  • 3) Wiling to provide own written informed consent to trial participation

排除标准

  • 1) Intake of any prescription drug for myocardial infarction, angina or bleeding disorders
  • 2) Intake of aspirin, anti-coagulants or anti-platelet agents within 2 weeks prior to screening
  • 3) Intake of red ginseng, ginseng, fermented bean paste within 2 weeks prior to screening
  • 4) Uncontrolled hypertension (systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg)
  • 5) Uncontrolled diabetes mellitus (fasting glucose > 180mg/dl, or intake of hypoglycemic agents within 3 months prior to screening)
  • 6) Uncontrolled thyroid diseases
  • 7) Surgery under general anesthesia within 3 months prior to screening
  • 8) Serum creatinine > 2 x upper normal limit
  • 9) Serum alanine Transaminase, aspartate Transaminase > 3 x upper normal limit
  • 10) Subject with severe epigastric soreness or indigestion
  • 11) Participation of other clinical study within 3 months prior to screening
  • 12) Ineligible for study participation due to other reasons, according to the investigator’s judgment

研究者

相似试验

Clinical trial for the efficacy of CJ_AJ on blood... | 临床试验